IL28B rs12979860 polymorphism and zinc supplementation affect treatment outcome and liver fibrosis after direct-acting antiviral hepatitis C therapy

MLA

Sameh Saif, et al. “IL28B Rs12979860 Polymorphism and Zinc Supplementation Affect Treatment Outcome and Liver Fibrosis after Direct-Acting Antiviral Hepatitis C Therapy.” Journal of Genetic Engineering and Biotechnology, vol. 19, no. 1, Oct. 2021, pp. 1–10. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9aa7e904c800f53b864926edc8883cdb&authtype=sso&custid=ns315887.

APA

Sameh Saif, Mohamed A. Abdelrazek, Mohamed Hassany, Abdelfattah M. Attallah, Riham El Essawey, Marwa Aabdelghany, Aza Farid, Dalia Omran, Ayman Yosry, & Muhammad Abdel Ghaffar. (2021). IL28B rs12979860 polymorphism and zinc supplementation affect treatment outcome and liver fibrosis after direct-acting antiviral hepatitis C therapy. Journal of Genetic Engineering and Biotechnology, 19(1), 1–10.

Chicago

Sameh Saif, Mohamed A. Abdelrazek, Mohamed Hassany, Abdelfattah M. Attallah, Riham El Essawey, Marwa Aabdelghany, Aza Farid, Dalia Omran, Ayman Yosry, and Muhammad Abdel Ghaffar. 2021. “IL28B Rs12979860 Polymorphism and Zinc Supplementation Affect Treatment Outcome and Liver Fibrosis after Direct-Acting Antiviral Hepatitis C Therapy.” Journal of Genetic Engineering and Biotechnology 19 (1): 1–10. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9aa7e904c800f53b864926edc8883cdb&authtype=sso&custid=ns315887.